日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and haematological features of hyperhaemolysis in sickle cell disease: A case series from two tertiary care centres

镰状细胞病高溶血症的临床和血液学特征:来自两家三级医疗中心的病例系列研究

Kim, Jaehyup; Burner, James D; Webb, Christopher; Sarode, Ravi; Adkins, Brian D; Kypreos, Margaret; Ibrahim, Ibrahim F; Shen, Yu-Min; Yates, Sean G

A study of Iraqi patients with homocysteine remethylation disorders in a tertiary pediatric centre

一项针对伊拉克三级儿科中心同型半胱氨酸再甲基化障碍患者的研究

Al-Tai, Mays R; Kareem, Adel A; Saadi, Nebal W; Omran, Tawfig Ben; Abdul Majeed, Ban A; Ibrahim, Ibrahim F; Alattar, Lamia A

COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study

COVID-19 mRNA疫苗在镰状细胞病患者中的反应:ASH RC镰状细胞研究网络的一项研究

Anderson, Alan R; Strouse, John J; Manwani, Deepa; Brandow, Amanda M; Vichinsky, Elliott; Campbell, Andrew; Leavey, Patrick J; Nero, Alecia; Ibrahim, Ibrahim F; Field, Joshua J; Baer, Amanda; Soto-Calderon, Haideliza; Vincent, Lauren; Zhao, Yan; Santos, Jefferson J S; Hensley, Scott E; Mortier, Nicole; Lanzkron, Sophie; Neuberg, Donna; Abrams, Charles S

Tailoring caplacizumab administration using ADAMTS13 activity for immune-mediated thrombotic thrombocytopenic purpura

利用ADAMTS13活性调整卡普拉西珠单抗给药方案治疗免疫介导的血栓性血小板减少性紫癜

Yates, Sean G; Hofmann, Sandra L; Ibrahim, Ibrahim F; Shen, Yu-Min P; Green, Allen P; Sarode, Ravi

A case of hyperhemolysis syndrome in sickle cell disease and concomitant COVID-19

一例镰状细胞病合并新冠肺炎并发高溶血综合征的病例报告

Green, Allen; Jones, Heather; Nero, Alecia; Ibrahim, Ibrahim F; Sarode, Ravi; Scheid, Lisa M; Webb, Christopher B; Adkins, Brian D; Yates, Sean G

COVID-19 Associated 60-Day Acute VTE Events in Hospitalized Patients Can be Predicted By D-Dimer and Prior VTE but Not By Reticulated Platelets

新冠肺炎相关住院患者60天内急性静脉血栓栓塞事件可通过D-二聚体和既往静脉血栓栓塞史预测,但网织血小板计数不能预测。

Ladd, N; Lewis, G P; Ashraf, Bilal; Jeon-slaughter, Haekyung; Lee, Nicholas CJ; Bat, Taha; Choi, Sung-Hee; Chen, Weina; Thomas, Abey; Ibrahim, Ibrahim F

SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia.

SARS-CoV-2 感染与再生障碍性贫血和纯红细胞再生障碍性贫血相关

Lee Nicholas C J, Patel Bhavisha, Etra Aaron, Bat Taha, Ibrahim Ibrahim F, Vusirikala Madhuri, Chen Mingyi, Rosado Flavia, Jaso Jesse Manuel, Young Neal S, Chen Weina

Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy

来那度胺成功用于治疗与单克隆丙种球蛋白病相关的难治性获得性血管性血友病

Green, Allen; Shen, Yu-Min P; Nelson, Andrew T; Sarode, Ravi; Ibrahim, Ibrahim F; Cao, Jing; Afraz, Sajjad; Yates, Sean G

Immature Platelets and Disease Severity in Patients Hospitalized with Acute COVID-19 Who Are Vaccinated Against COVID-19

未成熟血小板与急性新冠肺炎住院患者接种新冠疫苗后的疾病严重程度

Kimmerlin, Quentin; Strassel, Catherine; Lee, Nicholas CJ; Jeon-Slaughter, Haekyung; Ibrahim, Ibrahim F; Bat, Taha; Choi, Sung-Hee

Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction?

COVID-19 血栓形成的生物标志物:高敏肌钙蛋白 I 和未成熟血小板分数的作用?

DU, J N; STAUFFER, M H; LEVIN, M; ROGERS, A G; Ashraf, Bilal; Jeon-slaughter, Haekyung; Webb, Christopher; Lee, Nicholas CJ; Chen, Weina; Choi, Sung-Hee; Bat, Taha; Ibrahim, Ibrahim F